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MelatoninAbstract Background: We compared the efﬁcacy of melatonin and pregabalin on perioperative
anxiety and postoperative pain in patients undergoing laparoscopic gynecological surgeries.
Methods: In this randomized double-blind study, 40 patients, 25–35 yr undergoing gynecological
surgeries were divided into 2 equal groups to receive either melatonin capsule 6 mg (Group M),
or pregabalin capsule 150 mg (Group P) 1 h before induction of general anesthesia. Our primary
outcome was preoperative acute anxiety level 1 h after drug administration, 1, 6, and 12 h after
operation. The secondary outcomes were postoperative visual analog scale (VAS) for pain, analge-
sic consumption, sedation level using the inverted observer’s assessment of alertness/sedation scale
(OAA/S) scale, and incidence of adverse effects.
Results: The anxiety scores decreased signiﬁcantly >50% after premedication in both groups com-
pared to baseline values (p< 0.01) with no statistically signiﬁcant difference between the two
groups (30.4 ± 4.5 in group M versus 31.7 ± 4.2 in group P, p> 0.05). Postoperative VAS for
pain, time for ﬁrst analgesic demand and number of patients requiring postoperative analgesia
did not differ between groups, and the sedation score was higher in melatonin group compared
to pregabalin group 1 h after drug (3.45 ± 0.7 versus 1.95 ± 0.6, p< 0.001, respectively) and at
90 D.A. Nasr, A.A. Abdellatifall the subsequent readings postoperatively with equal incidence of adverse effects in both groups.
Conclusion: Oral melatonin 6 mg or pregabalin 150 mg administered 1 h before operation had
reduced perioperative anxiety and postoperative pain in patients undergoing gynecological surger-
ies, without untoward sedative effects in the pregabalin group compared to melatonin group.
ª 2013 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists.1. Introduction
Preoperative anxiety serves a critical role in the chain of events
that control the postoperative pain response [1,2]. Numerous
studies have demonstrated a positive correlation between anx-
iety and pain, with less anxious patients experienced less post-
operative pain [3].
Young female patients and patients with no previous anes-
thetic experience had higher anxiety scores [4]. Although ben-
zodiazepines are effective in reducing preoperative anxiety, its
anxiolytic effect is frequently accompanied by undesirable
sedation and previous clinical studies failed to demonstrate a
positive impact on postoperative pain [5]. Gabapentinoids
might be a useful alternative to benzodiazepines as pregabalin
(an analog of gabapentin) which has been alleged to possess
anxiolytic and analgesic effects [6]. Also, several studies
reported that melatonin which is a hormone secreted by the
pineal gland, has analgesic potential in addition to its anxio-
lytic and sedative effects without disturbances of the cognitive
and psychomotor skills [7–10].
We designed this study to compare the efﬁcacy of melatonin
and pregabalin in reducing perioperative anxiety and postopera-
tive pain in patients undergoing laparoscopic gynecological
surgeries.
Our primary outcome was preoperative acute (state) anxi-
ety level and the secondary outcomes were postoperative pain
and analgesic consumption.2. Materials and methods
After approval of the local ethics committee and obtaining
informed written patient’s consent, 40 female patients, ASA
physical status I–II, 25–35 yr old scheduled for gynecological
surgeries (laparoscopic adhesiolysis for infertility) were
enrolled in this randomized, double-blind study. The study
was conducted at Ain shams Maternity hospital from May
2011 to April 2012. Details of the trial protocol can be
obtained from the department of Anesthesiology, Faculty of
Medicine, Ain Shams University.
Exclusion criteria included patients with clinically signiﬁ-
cant medical or psychiatric problems or were taking opioid-
containing medications on a long-term basis, history of
chronic pain, regular medication with analgesics, or allergic
to any of the study drugs.
The patients were randomly assigned using a computer-
generated random numbers into 2 equal groups to receive
either one melatonin capsule 6 mg (Melatonin 3 mg tablet;
Sigma Chemical, St. Louis, MO, Group M), or pregabalin cap-
sule (150 mg; Lyrica, Pﬁzer Inc., Group P) approximately 1 h
before induction of general anesthesia. To maintain blindness,
all drugs were prepared in identical-appearing capsules and
were put in numbered envelopes. The study drugs were
administered by the ward nurse who was not involved in anypart of the study later, and no other preoperative medication
was given.
Anxiety levels were assessed by a blinded observer using the
Spielberg state and trait anxiety inventory STAI [11], a score
for each ranging between 20 and 80 may then be calculated by
an investigator using a scoring key [12] with higher scores indicat-
ing more anxiety. Assessment was done before taking the study
drugs (preop), 1 h after (immediately before induction of general
anesthesia) by the same observer who assess it an hour before.
Postoperative assessment was performed at 1, 6, and 12 h after
operation by a different observer from the one who had carried
out the preoperative evaluation. They presented the test questions
in a random order to prevent order effects.
On arrival at the operating room, electrocardiogram, pulse
oximetry, and non-invasive arterial blood pressure were ap-
plied. Baseline vital signs were obtained and subsequent values
were recorded every 5 min throughout surgical procedure.
Anesthesia was induced with fentanyl 1.5 lg/kg and propofol
1.5–2 mg/kg until loss of eyelash reﬂex. Tracheal intubation
was facilitated with atracurium 0.5 mg/kg. Anesthesia was
maintained with isoﬂurane (1–2%) in 40% oxygen, and inter-
mittent doses of muscle relaxant to maintain adequate muscle
relaxation throughout the procedure. The respiratory tidal vol-
ume was adjusted to keep end-tidal CO2 at 4.8–5.2%. The iso-
ﬂurane concentration was adjusted to keep heart rate and
blood pressure within 20% of pre-induction values throughout
the anesthesia period. All surgical procedures were completed
by the same surgeon. At the end of surgery, atropine 0.02 mg/
kg and neostigmine 0.05 mg/kg were given IV for antagonism
of neuromuscular blockade. Time to awaken (from the end of
anesthesia until the patients opened their eyes on command)
was recorded.
All the patients were transferred to the post-anesthesia care
unit (PACU), and diclofenac 75 mg was prescribed every 6 h
or as requested by the patients. Postoperative pain intensity
was rated by the patients using a 0–10 cm visual analog scale
(VAS), with 0 = no pain and 10 = the worst pain imaginable,
and time to the ﬁrst dose of postoperative analgesia was re-
corded.) The patient’s level of sedation was assessed using
the inverted observer’s assessment of alertness/sedation
(OAA/S) scale with a score of 1 = awake, alert to 5 = asleep,
unarousable [13]. The ward nurses were instructed to omit the
six hourly doses if they considered that the patient was over se-
dated or pain free (pain level 6 4 on VAS, sedation levelP 3
on OAA/S). The postoperative data (e.g., vital signs, pain,
and sedation scale) were assessed at 30 min, 2 h, 4 h, 6 h, 8 h,
and 12 h after the end of surgery. The occurrence of any side
effects such as nausea, vomiting, respiratory depression, dizzi-
ness, tremors, diplopia, headache, and pruritus was recorded.
Postoperative nausea and vomiting were treated with 4 mg
IV ondansetron.
The patients, attending anesthesiologists, data observers,
and nurses in the recovery room who were involved in the pa-
tients’ care were all blinded to the study group assignment.
Figure 1 State and trait anxiety inventory score (STAI). Group
M=Melatonin group, Group P = Pregabalin group. Columns
are mean STAI and error bars are standard deviation.
Figure 2 Visual Analog Score (VAS). Group M=Melatonin
group, Group P = Pregabalin group. Columns are mean VAS and
error bars are standard deviation.
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patients’ preoperative level of anxiety 1 h after intake of study
drug. Based on a predicted 33% reduction from the patient’s
pretreatment (baseline), our sample size estimation indicated
that 18 patients per groupwould give a power of 0.8 at ana-error
0.05 for detecting a 33% reduction in preoperative anxiety.
Mean and standard deviations in preoperative anxiety were
derived fromMenigaux et al. [14] and thus the total sample size
was prospectively set of 40 patients. The statistical analysis was
performed using a standard SPSS software package (Chicago, IL).
Datawere expressed asmean values ± SD, percentages (%),
and numbers (n). One-way analysis of variance was used to
analyze continuous variables. Changes in VRS scores over time
were analyzed using repeated-measures analysis of variance.
Student’s t-test was used to analyze the parametric data, and dis-
crete (categorical) variables were analyzed using the v2 test, with
p values <0.05 were considered statistically signiﬁcant.
3. Results
Forty patients, 20 per group, were enrolled in the study and
none was excluded. There were no differences between the
two groups in patient demographics, duration of operation,
end-tidal isoﬂurane concentration for maintenance of anesthe-
sia and time to awaken from anesthesia (Table 1).
There were no signiﬁcant differences between the two
groups in baseline STAI score, and these scores decreased sig-
niﬁcantly >50% after premedication in both groups com-
pared to baseline values (p< 0.01) with no signiﬁcant
differences between the two groups 1 h after drug administra-
tion and at all the following postoperative readings (Fig. 1,
State and trait anxiety inventory score).
There were no signiﬁcant differences in postoperative VAS
for pain between the two groups (Fig. 2, Visual Analog Score).
The time for ﬁrst analgesic demand, and the number of
patients requiring diclofenac at 6 and 12 h postoperatively
were also similar in both groups (Table 2).
Patients who received melatonin premedication were more
sedated than those who received pregabalin 1 h after drug
administration, on arrival at the operating room, and at all
the subsequent readings postoperatively (p< 0.001) (Fig. 3).
There were no signiﬁcant differences in mean baseline vital
sign values (heart rate, blood pressure, and oxygen saturation)
or in subsequent values during operation and postoperatively
with no incidence of bradycardia, hypotension, or desaturation
requiring intervention in the two groups.Table 1 Patient demographics and operative characteristics.
Group M
(n= 20)
Group P
(n= 20)
Age (yr) 32.5 ± 4 31 ± 5
Weight (kg) 62.6 ± 4 60.8 ± 6
Height (cm) 160 ± 4 164 ± 7
ASA status (I:II) 16:4 17:3
Duration of operation (min) 88.5 ± 4.4 86 ± 7
Isoﬂurane % 1.2 ± 0.2 1.1 ± 0.3
Time to awaken (min) 11.2 ± 1.7 13 ± 2.1
Group M=Melatonin group, Group P = Pregabalin group.
Data expressed as mean ± SD, ratio.
There was no statistically signiﬁcant difference between the 2
groups.Patients who received melatonin premedication were more
sedated than those who received pregabalin 1 h after drug
administration, and at all the subsequent readings postopera-
tively Fig. 3, Inverted Observer’s assessment of Alertness/
Sedation Scale (OASS).
Three patients in the melatonin group and one patient in
the pregabalin group complained of dizziness and three pa-
tients in the melatonin group and one patient in the pregabalin
group complained of headache, no other adverse effects were
recorded in both groups.
4. Discussion
This current study showed that in female patients undergoing
gynecological surgeries, administration of oral melatonin 6 mg
or pregabalin 150 mg, 1 h before operation had equal efﬁcacy
in reducing perioperative anxiety and postoperative pain with-
out untoward sedative effects in the pregabalin group com-
pared to melatonin group.
To our knowledge, this was the ﬁrst study that compared the
2 active drugs, melatonin, and pregabalin as regarding their efﬁ-
cacy in reducing perioperative anxiety and postoperative pain.
Previous randomized studies had compared each of these drugs
either with placebo [15–20], with midazolam [21], or with
clonidine [22] in separate surveys. The selected doses of oral
melatonin (6 mg) and pregabalin 150 mg used in our study were
based on previous studies concluding that premedication with
melatonin at a dose of 0.2 mg/kg [9] and pregabalin at a dose
Table 2 Time to ﬁrst analgesic demand, and diclofenac consumption.
Group M (n= 20) Group P (n= 20) p-Value
Time to ﬁrst analgesic demand (min) 114.3 ± 4.8 118.1 ± 6.2 0.08
Diclofenac consumption No. of patients (%)
At 6 h 10(50%) 8(40%) 0.75
At 12 h 12(60%) 10(50%) 0.75
Group M=Melatonin group, Group P = Pregabalin group.
Values are mean ± SD or number of patients and%.
P> 0.05 is considered statistically nonsigniﬁcant.
Figure 3 Inverted Observer’s assessment of Alertness/Sedation
Scale (OASS). Data are mean sedation score and error bars are
standard deviation. Group M=Melatonin group, Group
P = Pregabalin group. Statistically signiﬁcant difference between
the 2 groups at all time points.
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fects without untoward adverse effects.
No differences in the anxiety scores were found between pa-
tients receiving melatonin and those receiving pregabalin 1 h
after drug administration and at all the postoperative readings.
The preoperative anxiolytic effect of melatonin (6–10 mg) was
supported in previous clinical trials in adults when compared
with placebo [8,17,18,21]. In the postoperative period, melato-
nin had shown to be associated with less anxiety compared
with placebo up to 48 h after surgery [21,22]. Only one study
had refuted melatonin’s anxiolytic effects although, this study
showed that the level of anxiety scores decreased 33% after
melatonin premedication [16].
As regarding pregabalin, there were contradicting data
about its anxiolytic efﬁcacy.
Single doses of pregabalin 150 mg [20] and 300 mg [19] have
been proved to reduce preoperative anxiety without any side
effects like dizziness or persisting sedation. On the other hand,
another study showed that pregabalin administration in doses
from 75 to 300 mg po though increased perioperative sedation
in a dose-related fashion, but failed to reduce preoperative
state anxiety and postoperative pain after minor elective sur-
gery procedures [18]. These previous studies used the simple
VAS for anxiety which is less accurate than the State-Trait
Anxiety Inventory score which we used as it is the most accu-
rate score for assessing anxiety [4].
The same timing of the anxiolytic action of both drugs is
related to their pharmacokinetics, where the time required
reaching peak plasma concentration of melatonin ranged from
0.25 h to 13 h [23] and that of pregabalin was approximately
1 h and steady state was achieved within 24–48 h [24].The postoperative pain scores in this study were similar in
the two groups. The postoperative analgesic effect of melato-
nin has been proved after abdominal hysterectomy under epi-
dural anesthesia [22] and in patients receiving IV regional
anesthesia [25]. A previous animal study has shown that sys-
temic melatonin provided dose-dependent antinociception
and enhanced morphine analgesia [26].
As regarding pregabalin, different doses 75, 150 and 300 mg
administered as single doses before surgery had reduced post-
operative pain and opioid consumption in the early postoper-
ative period only [18,20].
Melatonin impact on pain may be explained by the inter-
play between the melatonergic and GABAergic systems
[27,28], enhancement of endorphin levels and the antinocicep-
tion induced by opioid receptor agonists [29], and activation of
MT2 melatonin receptors in the dorsal horn of the spinal cord
[30]. Pregabalin appears to be a potent ligand for the alpha-2-
delta subunit of voltage-gated calcium channels in the central
nervous system that exhibits potent analgesic, and anxiolytic
activity in a range of animal models [24].
Patients receiving pregabalin were less sedated and did not
complain of any other adverse effects, and it was proved that
Pregabalin is well tolerated and associated with dose-depen-
dent adverse effects that are mild-to-moderate and are usually
transient [31]. This may have to do with the relatively low dose
of pregabalin we used (150 mg). As regarding adverse effects,
patients who received melatonin were more sedated and three
patients were dizzy, which was nearly similar to the results
proved by Ismail and Mowaﬁ who found that one patient in
their melatonin group complained of dizziness [17].
There were some limitations in this study, ﬁrst, we did not
include placebo group for ethical concerns and as our study
drugs had been compared with placebo in many previous tri-
als, and second, that the last record of data was done at 12 h
postoperative as all patients were discharged after that.
In conclusion, in female patients undergoing gynecological
surgeries, administration of oral melatonin 6 mg or pregabalin
150 mg, 1 h before operation had reduced perioperative anxi-
ety and postoperative pain, without untoward sedative effects
in the pregabalin group compared to melatonin group.
Conﬂict of interest
None.
References
[1] Ip HY, Abrishami A, Peng PW, Wong J, Chung F. Predictors of
postoperative pain and analgesic consumption: a qualitative
systematic review. Anesthesiology 2009;111:657–77.
Efﬁcacy of preoperative melatonin versus pregabalin on perioperative anxiety and postoperative pain 93[2] Kain ZN, Sevarino F, Alexander GM, Pincus S, Mayes LC.
Preoperative anxiety and postoperative pain in women
undergoing hysterectomy. A repeated-measures design. J
Psychosom Res 2000;49:417–22.
[3] Degrootk I, Boeke S, Duivenvoorden HJ, Bonke B, Passchier J.
Different aspects of anxiety as predictors of postoperative
anxiety and physical complaints. Personality Individ Differ
1996;21(6):929–36.
[4] Kindler C, Harms C, Amsler F, Ihde-Scholl T, Scheidegger D.
The visual analog scale allows effective measurement of
preoperative anxiety and detection of patients’ anesthetic
concerns. Anesth Analg 2000;90:706–12.
[5] Shafer A, White PF, Urquhart ML, Doze VA. Outpatient
premedication: use of midazolam and opioid analgesics.
Anesthesiology 1989;71:495–501.
[6] Kavoussi R. Pregabalin: from molecule to medicine. Eur
Neuropsychopharmacol 2006;16:128–33.
[7] Naguib M, Samarkandi AH. Premedication with melatonin: a
double-blind, placebo controlled comparison with midazolam.
Br J Anaesth 1999;82:875–80.
[8] Naguib M, Samarkandi AH. The comparative dose-response
effect of melatonin and midazolam for premedication of adult’s
patients: a double-blinded placebo-controlled study. Anesth
Analg 2000;91:473–9.
[9] Naguib M, Samarkandi AH, Moniem MA, Mansour Eel-D,
Alshaer AA, Al-Ayyaf HA, Fadin A, Alharby SW. The effects
of melatonin premedication on propofol and thiopental
induction dose-response curves: a prospective, randomized,
double-blind study. Anesth Analg 2006;103:1448–52.
[10] Caumo W, Torres F, Moreira Jr NL, Auzani JA, Monteiro CA,
Londero G, Ribeiro DF, Hidalgo MP. The clinical impact of
preoperative melatonin on postoperative outcomes in patients
undergoing abdominal hysterectomy. Anesth Analg
2007;105:1263–71.
[11] Maranets I, Kain ZN. Preoperative anxiety and intraoperative
anesthetic requirement. Anesth Analg 1999;89:1346–51.
[12] Morley AP, Papageorgiou CH, Marinaki AM, Cooper DJ,
Lewis CM. The effect of preoperative anxiety on induction of
anesthesia with propofol. Anaesthesia 2008;63:467–73.
[13] Chernik DA, Gillings D, Laine H, Hendler J, Silver JM,
Davidson AB, Schwam EM, Siegel JL. Validity and reliability of
the Observer’s Assessment of Alertness/Sedation Scale: study
with intravenous midazolam. J Clin Psychopharmacol 1990;10:
244–51.
[14] Menigaux C, Adam F, Guignard B, Sessler DI, Chauvin M.
Preoperative gabapentin decreases anxiety and improves early
functional recovery from knee surgery. Anesth Analg
2005;100:1394–9.
[15] Yousaf F, Seet E, Venkatraghavan L, Abrishami A, Chung F.
Efﬁcacy and safety of melatonin as an anxiolytic and analgesic
in the perioperative period: a qualitative systematic review of
randomized trials. Anesthesiology 2010;113:968–76.
[16] Capuzzo M, Zanardi B, Schifﬁno E, Buccoliero C, Gragnaniello
D, Bianchi S, Alvisi R. Melatonin does not reduce anxiety morethan placebo in the elderly undergoing surgery. Anesth Analg
2006;103:121–3.
[17] Ismail SA, Mowaﬁ HA. Melatonin provides anxiolysis,
enhances analgesia, decreases intraocular pressure, and
promotes better operating conditions during cataract surgery
under topical anesthesia. Anesth Analg 2009;108:1146–51.
[18] White P, Tufanogullari B, Taylor J, Klein K. The effect of
pregabalin on preoperative anxiety and sedation levels: a dose-
ranging study. Anesth Analg 2009;108:1140–5.
[19] Gonano C, Latzke D, Sabeti M, Kettner SC, Chiari A, Gustorff
B. The anxiolytic effect of pregabalin in outpatients undergoing
minor orthopedic surgery. J Psychopharmacol 2011;25(2):
249–53.
[20] Spreng U, Dahl V, Ræder J. Effect of a single dose of pregabalin
on post-operative pain and pre-operative anxiety in patients
undergoing discectomy. Acta Anaesthesiol Scand 2011;55:
571–6.
[21] Acil M, Basgul E, Celiker V, Karago¨z AH, Demir B, Aypar U.
Perioperative effects of melatonin and midazolam
premedication on sedation, orientation, anxiety scores, and
psychomotor performance. Eur J Anaesthesiol 2004;21:553–7.
[22] Caumo W, Levandovski R, Paz M. Preoperative anxiolytic
effect of melatonin and clonidine on postoperative pain and
morphine consumption in patients undergoing abdominal
hysterectomy: a double-blind, randomized. Placebo-Controlled
Study. J Pain 2009;10:100–8.
[23] Chase JE, Gidal BE. Melatonin: therapeutic use in sleep
disorders. Ann Pharmacother 1997;31(10):1218–26.
[24] Ben-Menachem E. Pregabalin pharmacology and its relevance
to clinical practice. Epilepsia 2004;45(6):13–8.
[25] Mowaﬁ HA, Ismail SA. Melatonin improves tourniquet
tolerance and enhances postoperative analgesia in patients
receiving intravenous regional anesthesia. Anesth Analg
2008;107:1422–6.
[26] Kim SY, Jeong JJ, Chung WY, Kim HJ, Nam KH, Shim YH.
Perioperative administration of pregabalin for pain after robot-
assisted endoscopic thyroidectomy: a randomized clinical trial.
Surg Endosc 2010;24:2776–81.
[27] Golombek DA, Escolar E, Burin LJ, De Brito-Sanchez MG,
Cardinali DP. Time-dependent melatonin analgesia in mice:
inhibition by opiate or benzodiazepine antagonism. Eur J
Pharmacol 1991;194:25–30.
[28] Golombek DA, Martini M, Cardinali DP. Melatonin as an
anxiolytic in rats: time dependence and interaction with the
central GABAergic system. Eur J Pharmacol 1993;237:
231–6.
[29] Yu CX, Zhu B, Xu SF, Cao XD, Wu GC. The analgesic effects
of peripheral and central administration of melatonin in rats.
Eur J Pharmacol 2000;403:49–53.
[30] Yu CX, Zhu CB, Xu SF, Cao XD, Wu GC. Selective MT2
melatonin receptor antagonist blocks melatonin-induced
antinociception in rats. Neurosci Lett 2000;282:161–4.
[31] Gajraj NM. Pregabalin: its pharmacology and use in pain
management. Anesth Analg 2007;105:1805–15.
